Nerve Repair and Regeneration Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32
                     Global Nerve Repair and 
Regeneration Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " N e r v e  R e p a i r  a n d  R e g e n e r a t i o n  
M a r k e t :  G l o b a l  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  2 0 2 4 -
2 0 3 2 , "  t h e  g l o b a l  n e r v e  r e p a i r  a n d  r e g e n e r a t i o n  m a r k e t  s i z e  r e a c h e d  U S $  8 . 6  B i l l i o n  i n  
2 0 2 3 .
Report N e r v e  r e p a i r  a n d  r e g e n e r a t i o n  ( N R a R )  i s  a  m e th o d  o f  n e u r a l  t i s s u e  e n g i n e e r i n g  t h a t  a i d s  
i n  t h e  h e a l i n g  o f  n e r v e  i n j u r i e s .  I t  h e l p s  i n  r e s t o r i n g  n o r m a l  n e r v e  f u n c t i o n  t h a t  h a s  b e e n  
d i s r u p te d  d u e  t o  v a r i o u s  c a u s e s ,  s u c h  a s  p r e s s u r e ,  s e v e r e  t r a u m a ,  s t r e t c h i n g ,  o r  c u t t i n g .  
Highlight and T h e  p r o c e s s  o f  n e r v e  r e p a i r  a n d  r e g e n e r a t i o n  i n v o l v e s  a  c o m p l e x  i n t e r p l a y  o f  b i o l o g i c a l  
p r o c e s s e s ,  i n c l u d i n g  t h e  g r o w t h  a n d  m i g r a t i o n  o f  n e r v e  c e l l s ,  t h e  f o r m a t i o n  o f  n e w  b l o o d  
v e s s e l s ,  a n d  t h e  s y n th e s i s  o f  v a r i o u s  p r o te i n s  a n d  s i g n a l i n g  mo l e c u l e s .  
Description T h e  t e c h n i q u e  e m p l o y s  v a r i o u s  b i o m a te r i a l s ,  s u c h  a s  n e r v e  c o n d u i t s ,  p r o t e c t o r s ,  w r a p s ,  
a n d  c o n n e c t o r s ,  a l o n g  w i t h  n e u r o - s t i m u l a t i o n  a n d  n e u r o m o d u l a t i o n  d e v i c e s  t h a t  a r e  u s e d  
f o r  d i r e c t  n e u r o p a t h y ,  n e r v e  g r a f t i n g ,  s t e m  c e l l  t h e r a p y  a n d  t r a n s c u t a n e o u s ,  t r a n s c r a n i a l  
m a g n e t i c ,  s p i n a l  c o r d ,  d e e p  b r a i n ,  s a c r a l  n e r v e ,  a n d  v a g u s  n e r v e  s t i m u l a t i o n .
R e q u e s t  f o r  a  P D F  s a m p le  o f  t h is  r e p o r t :  
h t t p s : / / w w w . i m a r c g r o u p . c o m /n e r v e - r e p a i r - r e g e n e r a t i o n - m a r k e t / r e q u e s t s a m p l e
Report Description
G lo b a l  N e r v e  R e p a i r  a n d  R e g e n e r a t i o n  M a r k e t  T r e nd s :
T h e  i n c r e a s i n g  p r e v a l e n c e  o f  c h r o n i c  n e u r o l o g i c a l  d i s o r d e r s  i s  d r i v i n g  t h e  g l o b a l  m a r k e t .  A l o n g  w i t h  t h i s ,  t h e  r i s i n g  a w a r e n e s s  
r e g a r d i n g  t h e  b e n e f i t s  o f  n e r v e  r e p a i r  a n d  r e g e n e r a t i o n  t e c h n i q u e s  a m o n g  p a t i e n t s  a n d  h e a l t h c a r e  p r o f e s s i o n a l s  i s  c a t a l y z i n g  t h e  
d e m a n d .  M o r e o v e r ,  t h e  d e v e l o p m e n t  o f  i n n o v a t i v e  p r o d u c t s ,  s u c h  a s  n e r v e  c o n d u i t s ,  n e r v e  w r a p s ,  a n d  n e r v e  p r o t e c t o r s ,  a r e  
a c t i n g  a s  a n o t h e r  g r o w th - i n d u c i n g  f a c t o r .  I n  l i n e  w i t h  t h i s ,  t h e  e a s y  a v a i l a b i l i t y  o f  n u m e r o u s  m e d i c i n e s  f o r  m a n a g i n g  c e n t r a l  
n e r v o u s  s y s t e m  ( C N S )  a n d  p e r i p h e r a l  n e r v o u s  s y s t e m  i l l n e s s e s ,  i n c l u d i n g  P a r k i n s o n ' s  d i s e a s e ,  A l z h e i m e r ' s ,  a n d  m u l t i p l e  
s c l e r o s i s ,  i s  s u p p o r t i n g  t h e  o v e r a l l  d e m a n d .  A d d i t i o n a l l y ,  v a r i o u s  t e c h n o l o g i c a l  a d v a n c e m e n t s  i n  s t e m  c e l l  t h e r a p y  a n d  t h e  
d e v e l o p m e n t  o f  i n n o v a t i v e  n e u r o m o d u l a t i o n  d e v i c e s  a r e  a u g m e n t i n g  t h e  m a r k e t .  F u r t h e r mo r e ,  i n c r e a s i n g  f u n d i n g  b y  t h e  
g o v e r n m e n t s  f o r  r e s e a r c h  a n d  d e v e l o p m e n t  ( R & D )  a c t i v i t i e s  t o  d e v e l o p  n e w  t r e a t m e n ts  a n d  p r o d u c t s  i s  p r o v i d i n g  a  b o o s t  t o  t h e  
d e m a n d .  A p a r t  f r o m  th i s ,  t h e  g r o w i n g  a d o p t i o n  o f  m i n i m a l l y  i n v a s i v e  s u r g i c a l  p r o c e d u r e s  i s  a l s o  f u e l l i n g  t h e  d e m a n d  f o r  n e r v e  
r e p a i r  a n d  r e g e n e r a t i o n  p r o d u c t s .  O t h e r  f a c to r s ,  s u c h  a s  r i s i n g  h e a l t h c a r e  e x p e n d i t u r e s  o f  t h e  m a s s e s ,  s i g n i f i c a n t  i mp r o v e m e n ts  
i n  t h e  m e d i c a l  i n f r a s t r u c t u r e  a n d  t h e  g r o w i n g  g e r i a t r i c  p o p u l a t i o n ,  a r e  p r o j e c t e d  t o  p r o p e l  t h e  m a r k e t  f u r t h e r .
L o o k in g  f o r w a r d ,  t h e  m a r k e t  i s  a n t i c i p a t e d  t o  r e a c h  a  v a lu e  o f  U S $  2 0 . 7  B i l l i o n  b y  2 0 3 2 ,  e x h i b i t i n g  a  g r o w t h  r a t e  ( C A G R )  o f  
1 0 %  d u r i n g  2 0 2 4 - 2 0 3 2 .
V ie w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w w w . i m a r c g r o u p . c o m / n e r v e - r e p a i r - r e g e n e r a t i o n - m a r k e t
Breakup by Surgery:
• Direct  Nerve Repair /Neurorrhaphy
• Nerve Graft ing
• Stem Cel l  Therapy
• Neurost imulat ion and Neuromodulat ion 
Surgeries
Report 
Breakup by Product:
Segmentation • Biomater ial
• Neurost imulat ion and Neuromodulat ion Devices
o Spinal  Cord St imulat ion Devices
o Deep Brain St imulat ion Devices
o Sacral  Nerve St imulat ion Devices
o Vagus Nerve St imulat ion Devices
o Gastr ic E lectr ic St imulat ion Devices
Breakup by End User:
• Hospitals and Cl inics
• Ambulatory Surgical  Centers
Breakup by Region:
• North America
Report • Asia-Pacifi c
Segmentation • Europe
• Latin America
• Middle East and Afr ica
• Abbott Laboratories
• Alafair Biosciences Inc.
• AxoGen Inc.
• Baxter International  Inc.
Competitive 
• Boston Scient ifi c Corporation
Landscape • Col lagen Matrix Inc.
with Key • Integra Li fesciences Corporation
• Medtronic plc
Players
• Polyganics BV
• Soterix Medical  Inc.
• Stryker Corporation
• Synapse Biomedical  Inc.
What was the size of the global nerve repair and 
regeneration market in 2023?
What is the expected growth rate of the global nerve 
repair and regeneration market during 2024-2032?
What are the key factors driving the global nerve repair 
and regeneration market?
Key 
What has been the impact of COVID-19 on the global 
nerve repair and regeneration market?
Questions 
What is the breakup of the global nerve repair and 
Answered in regeneration market based on the surgery?
the Report What is the breakup of the global nerve repair and 
regeneration market based on the product?
What is the breakup of the global nerve repair and 
regeneration market based on the end user?
What are the key regions in the global nerve repair and 
regeneration market?
Who are the key players/companies in the global nerve 
repair and regeneration market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  N e r v e  R e p a i r  a n d  R e g e n e r a t i o n  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  S u r g e r y
    6 . 1     D i r e c t  N e r v e  R e p a i r / N e u r o r r h a p h y
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     N e r v e  G r a f t i n g
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     S t e m  C e l l  T h e r a p y
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     N e u r o s t i m u l a t i o n  a n d  N e u r o m o d u l a t i o n  S u r g e r i e s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  P r o d u c t
    7 . 1     B i o m a t e r i a l
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     N e u r o s t i m u l a t i o n  a n d  N e u r o m o d u l a t i o n  D e v i c e s
        7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  K e y  S e g m e n t s
           7 . 2 . 2 . 1  S p i n a l  C o r d  S t i m u l a t i o n  D e v i c e s
Table of            7 . 2 . 2 . 2  D e e p  B r a i n  S t i m u l a t i o n  D e v i c e s
           7 . 2 . 2 . 3  S a c r a l  N e r v e  S t i m u l a t i o n  D e v i c e s
           7 . 2 . 2 . 4  V a g u s  N e r v e  S t i m u l a t i o n  D e v i c e s
Contents            7 . 2 . 2 . 5  G a s t r i c  E l e c t r i c  S t i m u l a t i o n  D e v i c e s        7 . 2 . 3  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  E n d  U s e r
    8 . 1     H o s p i t a l s  a n d  C l i n i c s
        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     A m b u l a t o r y  S u r g i c a l  C e n t e r s
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  R e g i o n
    9 . 1     N o r t h  A m e r i c a
        9 . 1 . 1  U n i t e d  S t a t e s
           9 . 1 . 1 . 1  M a r k e t  T r e n d s
           9 . 1 . 1 . 2  M a r k e t  F o r e c a s t     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
ht t ps : / /w ww. i ma rc gro up . c o m /n e rve - rep a i r- regen e ra t i o n -m a rk
e t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: